Cargando…
Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients
BACKGROUND: Disulfidptosis is a recently discovered form of cell death. However, its biological mechanisms in bladder cancer (BCa) are yet to be understood. METHODS: Disulfidptosis-related clusters were identified by consensus clustering. A disulfidptosis-related gene (DRG) prognostic model was esta...
Autores principales: | Chen, Hualin, Yang, Wenjie, Li, Yingjie, Ma, Lin, Ji, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266281/ https://www.ncbi.nlm.nih.gov/pubmed/37325625 http://dx.doi.org/10.3389/fimmu.2023.1198878 |
Ejemplares similares
-
Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
por: Ma, Xiaoqing, et al.
Publicado: (2023) -
Neoadjuvant immunotherapy and chemoimmunotherapy for stage II-III muscle invasive bladder cancer
por: Chen, Hualin, et al.
Publicado: (2022) -
Machine learning-based identification of tumor-infiltrating immune cell-associated model with appealing implications in improving prognosis and immunotherapy response in bladder cancer patients
por: Chen, Hualin, et al.
Publicado: (2023) -
Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning
por: Zhao, Yi, et al.
Publicado: (2023) -
Identification of disulfidptosis-related subgroups and prognostic signatures in lung adenocarcinoma using machine learning and experimental validation
por: Wang, Yuzhi, et al.
Publicado: (2023)